Your browser doesn't support javascript.
loading
Taking the EZ way: Targeting enhancer of zeste homolog 2 in B-cell lymphomas.
Morschhauser, Franck; Salles, Gilles; Batlevi, Connie Lee; Tilly, Hervé; Chaidos, Aristeidis; Phillips, Tycel; Burke, John; Melnick, Ari.
Afiliação
  • Morschhauser F; Univ. Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France. Electronic address: franck.morschhauser@chru-lille.fr.
  • Salles G; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Batlevi CL; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Tilly H; Department of Hematology, INSERM U1245, Centre Henri Becquerel and Rouen University, Rouen, France.
  • Chaidos A; The Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Faculty of Medicine, Imperial College London & Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Phillips T; Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Burke J; US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, Aurora, CO, USA.
  • Melnick A; Weill Cornell Medicine, New York, NY, USA. Electronic address: amm2014@med.cornell.edu.
Blood Rev ; 56: 100988, 2022 11.
Article em En | MEDLINE | ID: mdl-35851487
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article